Titanium complexes bearing 2,6-bis(o-hydroxyalkyl)pyridine ligands in vitro cytotoxicity against triple-negative breast-cancer cells

I. Ni Chen, Prasanna Kumar Ganta, Shou Jie Chung, Yu Lun Chang, Heng Yi Chang, Shangwu Ding, Hsuan Ying Chen, Chien Chih Chiu, Kuo Hui Wu

Research output: Contribution to journalArticlepeer-review

Abstract

Three titanium (Ti) compounds bearing 2,6-bis(o-hydroxyalkyl)pyridine ligands were synthesized, and used in vitro cytotoxicity against triple-negative breast cancer (TNBC) MDA-MB-231 cells was studied. The results of in vitro cytotoxicity of the complexes against TNBC cells revealed that (HLMeTi-O)4 (IC50 = 0.91 μM) exerted a significant inhibitory effect on the proliferation of TNBC cells. Thus, titanium alkoxide complexes as nonplatinum complex could be used for structural optimization for treating breast cancer cells in the future.

Original languageEnglish
Pages (from-to)871-877
Number of pages7
JournalJournal of the Chinese Chemical Society
Volume68
Issue number5
DOIs
StatePublished - May 2021

Keywords

  • 2,6-bis(o-hydroxyalkyl)pyridine ligand
  • in vitro cytotoxicity
  • nonplatinum complex
  • pincer complexes
  • titanium complex
  • TNBC cell

Fingerprint

Dive into the research topics of 'Titanium complexes bearing 2,6-bis(o-hydroxyalkyl)pyridine ligands in vitro cytotoxicity against triple-negative breast-cancer cells'. Together they form a unique fingerprint.

Cite this